Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured Brain

Jia Nong(University of Pennsylvania), Oscar A. Marcos‐Contreras(University of Pennsylvania), Colin F. Greineder(Translational Therapeutics (United States)), Scott E. Kasner(University of Pennsylvania), Marco E. Zamora(Translational Therapeutics (United States)), Alvin J. Mukalel(University of Pennsylvania), Viviana Zuluaga‐Ramirez(Temple University), Vladimir R. Muzykantov(Translational Therapeutics (United States)), Raisa Y. Kiseleva(Translational Therapeutics (United States)), Serena Omo‐Lamai(University of Pennsylvania), Yuri Persidsky(Temple College), Carlos H. Villa(Center for Biologics Evaluation and Research), Jacob W. Myerson(Translational Therapeutics (United States)), Drew Weissman(California University of Pennsylvania), Michael J. Mitchell(California Institute for Regenerative Medicine), Patrick M. Glassman(Translational Therapeutics (United States)), Kartik Bhamidipati(Translational Therapeutics (United States)), Alba Rodríguez-García(Fundació Clínic per a la Recerca Biomèdica), Zhicheng Wang(Translational Therapeutics (United States)), Silvia Muro(Institució Catalana de Recerca i Estudis Avançats), Xijing Gong(University of Pennsylvania), Landis R. Walsh(Translational Therapeutics (United States))
ACS Nano
July 11, 2023
Cited by 28


Related Papers